Cancer Grand Challenges is a global research initiative that is building an elite, interdisciplinary community to tackle cancer’s most complex problems.
Co-founded in 2020 by the two largest funders of cancer research in the world, Cancer Research UK and the National Cancer Institute in the US, it aims to accelerate high-impact research and translate discoveries for public and patient benefit through global team science.
Challenges
The seven new set of challenges are elaborated below:
- AI-human collaborations in cancer
- Cancer avoidance
- The dark proteome
- Mechanisms driving mutational signatures
- The nervous system and cancer
- Rewiring cancer cells
- TME dynamics
Eligibility
- The Cancer Grand Challenges initiative supports teams involving investigators from institutions across the globe and from different disciplines.
- Teams must be international in nature, with no more than 70% of the activity (and funding) being based in a single country.
- There is no requirement for teams to be led by, or include investigators, who are based in the UK or US or any other specific country.
Funding
- Cancer Grand Challenges awards provide up to £20 million for the direct costs incurred in accepting the funding.
- No more than 70% of a team’s funding may be issued to institutions in a single country.
How to apply
To apply, each team will need to submit a pre-submission questionnaire on the call website. This will be used to check eligibility against the criteria set out in sections 3 and 4 of these guidelines.
Consult Call Guidelines here for additional information and how to apply.
Contact
To discuss a prospective application, please contact: email info@cancergrandchallenges.org or call +44 (0) 20 3469 8855